Oppenheimer Maintains Outperform on Teladoc Health, Raises Price Target to $10
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $7 to $10.
Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $7 to $10.